Show simple item record

dc.contributor.authorWong, YNS
dc.contributor.authorJoshi, K
dc.contributor.authorPule, M
dc.contributor.authorPeggs, KS
dc.contributor.authorSwanton, C
dc.contributor.authorQuezada, SA
dc.contributor.authorLinch, M
dc.date.accessioned2018-02-20T15:17:59Z
dc.date.issued2017-06
dc.identifier.citationThe Lancet Oncology, 2017, 18 (6), pp. e341 - e353
dc.identifier.issn1470-2045
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1449
dc.identifier.doi10.1016/s1470-2045(17)30327-3
dc.format.extente341 - e353
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.titleEvolving adoptive cellular therapies in urological malignancies
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/s1470-2045(17)30327-3
rioxxterms.licenseref.startdate2017-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfThe Lancet Oncology
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume18
pubs.embargo.termsNot known
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record